Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-16

FDA Approved: RIFAMPIN — Supplemental Application (EPIC PHARMA, LLC)

View source ↗

Summary

FDA approved a supplemental application for Rifampin from Epic Pharma, LLC. The approval likely updates labeling or indications for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RIFAMPIN (RIFAMPIN)

Snippet

SUPPL AP for RIFAMPIN (RIFAMPIN)